Advertisement
Home Blog Page 43

Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination

0

Increased risk for myocarditis, pericarditis seen one to two weeks after COVID-19 mRNA vaccination

Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs

0

Prescriptions for GLP-1 RAs less common among White teens versus Black, Hispanic teens

Radon Exposure Tied to Higher Risk for Childhood Leukemia

0

Findings seen even for exposure below the U.S. Environmental Protection Agency guidelines

Gut Flora Differs in Patients With Epilepsy and Cognitive Dysfunction

0

Collinsella, Oscillospirales, and Ruminococcaceae have a greater impact on epilepsy with cognitive dysfunction

Risk for Type 2 Diabetes Increased for Children After SARS-CoV-2 Infection

0

Risk increased in the six months after infection; elevated risk also seen in subpopulation with overweight, obesity and hospitalized patients

Rate of Layperson-Administered Naloxone Increased From 2020 to 2022

0

Overall, though, naloxone administration rates decreased 6.1 percent during the study period

IOTA ADNEX at 10 Percent Has Higher Sensitivity for Ovarian Cancer

0

Sensitivity higher, but some loss seen in specificity, when compared with Risk of Malignancy 1 index at threshold of 250

FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

0
By Robin Foster HealthDay Reporter TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the...

Wayfinding Task on Smartphone Can Detect Subjective Cognitive Decline

0

Performance measures extracted from GPS and user data differentiated between those with subjective cognitive decline, cognitively healthy adults

2008 to 2022 Saw Rise in Industry-Sponsored Adult Cancer Clinical Trials

0

From 2018 to 2022, industry-to-federally sponsored trial ratio was 8.1